A J Blasco

Summary

Publications

  1. ncbi [Efficiency of biologic agents in the treatment of moderate to severe psoriasis]
    A J Blasco
    Técnicas Avanzadas de Investigación en Servicios de Salud, Madrid, Espana
    Actas Dermosifiliogr 100:792-803. 2009
  2. ncbi [Cost of childhood asthma in Spain: a cost evaluation model based on the prevalence]
    A J Blasco Bravo
    Técnicas Avanzadas de Investigación en Servicios de Salud TAISS, Madrid, Spain
    An Pediatr (Barc) 74:145-53. 2011

Collaborators

Detail Information

Publications2

  1. ncbi [Efficiency of biologic agents in the treatment of moderate to severe psoriasis]
    A J Blasco
    Técnicas Avanzadas de Investigación en Servicios de Salud, Madrid, Espana
    Actas Dermosifiliogr 100:792-803. 2009
    ..OBJECTIVE. To estimate the cost/efficacy ratios of adalimumab, etanercept, infliximab, and efalizumab in the management of moderate to severe psoriasis...
  2. ncbi [Cost of childhood asthma in Spain: a cost evaluation model based on the prevalence]
    A J Blasco Bravo
    Técnicas Avanzadas de Investigación en Servicios de Salud TAISS, Madrid, Spain
    An Pediatr (Barc) 74:145-53. 2011
    ..Asthma is the most common chronic disease in childhood, reduces the quality of life of children and their families, and produces high social and health care costs. In Spain, the cost of managing paediatric asthma is unknown...